$76.72
+0.670 (+0.88%)
At Close: Jun 18, 2026
IFF Completes Divestiture of Pharma Solutions Business Unit
02:00am, Thursday, 01'st May 2025
NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF) today announced that it has successfully completed the previously announced divestiture of its Pharma Solutions business unit to Roquette. “The completion
International Flavors (IFF) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
11:07am, Tuesday, 29'th Apr 2025
International Flavors (IFF) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
IFF Pharma Solutions to Showcase Portfolio at Excipient World 2025
05:00pm, Monday, 28'th Apr 2025
NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF) Pharma Solutions, a global leader in polymer innovations, will showcase its sustainable solutions at Excipient World 2025. The team will feature sustainable
IFF Expands Pet Portfolio with Latest Science-driven Solutions
08:00am, Monday, 28'th Apr 2025
NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF), a global powerhouse in bioscience and innovation, today announced a groundbreaking expansion of its pet portfolio. This launch marks a significant leap in I
IFF Pharma Solutions to Showcase Plant-Based Dietary Supplement Ingredients and Technical Expertise at Vitafoods™ Europe 2025
02:00am, Tuesday, 22'nd Apr 2025
NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF) Pharma Solutions is excited to announce its participation at Vitafoods™ Europe 2025, the premier global nutraceutical event. The team will showcase its cut
IFF Opens Dubai Creative Center With Perfumery Art Studio
12:00am, Wednesday, 16'th Apr 2025
DUBAI, United Arab Emirates--(BUSINESS WIRE)--IFF (NYSE: IFF) announced the inauguration of its Scent Dubai Creative Center, a 2,000-square-meter addition to the company's facility in the Dubai Scienc
IFF to Release First Quarter 2025 Results on May 6, 2025
04:15pm, Monday, 14'th Apr 2025
NEW YORK--(BUSINESS WIRE)---- $IFF--IFF (NYSE:IFF) today announced that it will release its first quarter 2025 earnings results following the market close on Tuesday, May 6, 2025. The management team
International Flavors to Boost Presence in Mexico With New Facility
10:05am, Monday, 14'th Apr 2025
IFF plans to consolidate the majority of its business operations in Mexico at a new site within the Tecnoparque business complex to meet customer demand in the region.
Strength Seen in International Flavors (IFF): Can Its 9.2% Jump Turn into More Strength?
10:15am, Thursday, 10'th Apr 2025
International Flavors (IFF) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price
IFF Opens Mexico Business Hub at Tecnoparque
08:00am, Thursday, 10'th Apr 2025
NEW YORK--(BUSINESS WIRE)--To further strengthen its ability to serve customers with leading innovations, IFF (NYSE: IFF) announced it will combine the majority of its business operations in Mexico at
IFF Unveils Cutting-Edge Citrus Innovation Center in Florida
08:00am, Wednesday, 09'th Apr 2025
NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF) today announced the opening of the Citrus Innovation Center in Lakeland, Florida, in partnership with Florida Polytechnic University. This 30,000 square foot
IFF Pharma Solutions Launches Low Nitrite METHOCEL™ HPMC for Nitrosamine Mitigation
08:00am, Tuesday, 08'th Apr 2025
NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF) Pharma Solutions, a global leader in polymer innovations, today announced the launch of Low Nitrite METHOCEL™ hydroxypropyl methylcellulose (HPMC), a range
IFF Introduces Science of Performance: A New Approach to Elevating Scent Design
03:00am, Tuesday, 01'st Apr 2025
PARIS--(BUSINESS WIRE)--IFF (NYSE: IFF) unveils its Science of Performance program, a comprehensive, science-driven suite that enhances fragrance creation by increasing efficiency and precision to man
IFF and Kemira Form Joint Venture To Produce Sustainable Biobased Materials at Scale
02:00am, Thursday, 27'th Mar 2025
NEW YORK--(BUSINESS WIRE)--IFF (NYSE:IFF) and Kemira announced the formation of Alpha Bio, a joint venture aimed at commercial-scale production of renewable biobased materials. With an investment of a
IFF Pharma Solutions Brings Next-Gen Excipient Innovations to CPHI Japan 2025
07:00pm, Monday, 24'th Mar 2025
TOKYO--(BUSINESS WIRE)--IFF (NYSE:IFF) Pharma Solutions will showcase its cutting-edge excipient technologies at CPHI Japan 2025. The IFF Pharma Solutions team will highlight its innovations in oral d
Sign In
Buy IFF